Upgrade to SI Premium - Free Trial

Lilly's (LLY) OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape

July 12, 2019 8:03 AM
Eli Lilly and Company (NYSE: LLY) announced the upcoming presentation of data highlighting inconsistent and sub-optimal treatment patterns that people ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles